PharmaBoardroom

Katrien de Vos – Country President, AstraZeneca Switzerland

AstraZeneca's recently arrived Switzerland country president, Katrien de Vos, gives her first impressions of the Swiss market and how she hopes to…

Life Science VC Funding in Japan: Signs of Growth & Untapped…

Toshio Fujimoto, MD, MBA, the General Manager of Shonan Health Innovation Park examines why Japan – despite being well established as one of the…

Australia: Growing Clinical Trials Even in Pandemic’s Wake

In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of New South Wales, Medicine, St.…

The Skills That Regional Pharma Leaders Need in the Middle East…

Mohamed Nasser, Amgen’s general manager for the vast Middle East & Africa (MEA) region, leverages his considerable experience managing teams…

USA: Importance of the Patient Voice in Drug Development:…

Writing in the May edition of DIA’s Global Forum magazine, Erica Lyons, Sarrit Kovacs, Matthew Kowalik, and Jessica Lee from the Division of…

Bee Lim – Director, Healthcare Strategy & Marketing,…

UPS APAC's Bee Lim describes how the logistics giant responded to the unprecedented challenges thrown up by the COVID-19 pandemic, the trends that the…

Alejandro Paolini – Managing Director Mexico, Central…

Alejandro Paolini, Siemens Healthineers’ managing director for Mexico, Central America and Caribbean, dives into the medical technology industry’s…

Héctor Orellana – VP North Latin America, Medtronic

Medtronic’s VP for North Latin America, Héctor Orellana, outlines the largest company’s new vision for that region, their efforts and challenges…

IP PACT: A Journey, Not a Destination

The issue of COVID-19 vaccine access in developing nations has thrust intellectual property (IP) into global headlines. Against the backdrop of heated…